APLS
Apellis Pharmaceuticals, Inc.- Sector
- Biotechnology
- Last price
- $41.03
- As of
Share the APLS intelligence card
See APLS live in the terminal
Track APLS's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live APLS terminal, freeActive signals for APLS
- highCONSENSUS_BUY
3 tracked funds increased APLS this 2026Q1 - institutional consensus
- highINSTITUTIONAL_SURGE
Point72 Asset Management, L.P. added +600% to APLS (2026Q1)
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +138% to APLS (2026Q1)
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 99% of APLS (2026Q1)
- highINSTITUTIONAL_SURGE
D. E. Shaw & Co., Inc. added +1244% to APLS (2026Q1)
Top institutional holders of APLS (13F)
| Fund | Market value | % portfolio | QoQ |
|---|---|---|---|
| D. E. Shaw & Co., Inc. | $5.3M | 0.00% | +0.0% |
| D. E. Shaw & Co., Inc. | $5.2M | 0.00% | +0.0% |
| D. E. Shaw & Co., Inc. | $5.2M | 0.00% | , |
Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.
Recent SEC filings, APLS
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Related tickers
Catch the next move on names like this
New 13F filings, insider trades, and cross asset signals like the ones above, in your inbox each morning or live on Telegram. Free, no account.
One email a day. Unsubscribe anytime. We never sell your data.
See more APLS signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to APLSand get the insider, 13F, options, and confluence read in one view.
